Aims

Pharmacology and Toxicology Research is a peer-reviewed, open-access journal dedicated to disseminating high-quality research across the full spectrum of pharmacology and toxicology. Our mission is to serve as a comprehensive platform for scientists, clinicians, and healthcare professionals to share significant findings that advance understanding in these critical fields.

Scope

We welcome submissions that encompass, but are not limited to, the following areas:

• Experimental Pharmacology and Toxicology: Investigations into the effects of chemical agents on biological systems, including studies on drug efficacy, safety, and mechanisms of action.

• Clinical Pharmacology and Toxicology: Research focusing on the therapeutic application and adverse effects of drugs in humans, encompassing clinical trials, case studies, and pharmacovigilance reports.

• Molecular and Cellular Pharmacology: Studies exploring drug interactions at the molecular and cellular levels, including signal transduction, receptor binding, and genetic implications.

• Pharmacokinetics and Pharmacodynamics: Research on the absorption, distribution, metabolism, and excretion of drugs, as well as their biochemical and physiological effects.

• Toxicogenomics and Toxicoproteomics: Investigations into the genomic and proteomic responses to toxicants, aiming to elucidate mechanisms of toxicity and identify biomarkers.

• Environmental Toxicology: Studies assessing the impact of environmental pollutants on health, including ecotoxicology and risk assessment.

• Ethnopharmacology: Research on the pharmacological properties of traditional medicines and natural products, emphasizing their potential therapeutic applications and safety profiles.

• Drug Development and Design: Articles detailing the discovery and development of new therapeutic agents, including medicinal chemistry, high-throughput screening, and computational modeling.

• Regulatory Pharmacology and Toxicology: Discussions on the policies, guidelines, and ethical considerations governing drug approval and safety monitoring.

• Nanotoxicology: Research on the interactions between nanomaterials and biological systems, focusing on potential toxicological implications.

• Systems Pharmacology: Studies employing systems biology approaches to understand drug actions and interactions within complex biological networks.

• Pharmacogenomics and Personalized Medicine: Research exploring how genetic variations influence drug response, aiming to optimize therapeutic strategies for individual patients.

• Computational Pharmacology and Toxicology: Utilization of in silico models and simulations to predict drug behavior and toxicological outcomes.

• Behavioral Pharmacology: Studies examining the effects of drugs on behavior, including addiction research and neuropharmacology.

• Cardiovascular Pharmacology: Research focusing on the effects of drugs on the cardiovascular system, including mechanisms of action and therapeutic potential.

• Immunopharmacology: Studies on the modulation of the immune system by pharmacological agents, including immunotoxicology and immunotherapy.

• Reproductive and Developmental Toxicology: Research investigating the impact of chemical agents on reproduction and development, encompassing teratology and endocrine disruption studies.